During the past decade, Austin Speech Labs conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Austin Speech Labs" #1 collaborator was "Burke Medical Research Institute" with 1 trials as a collaborator, "National Institute on Deafness and Other Communication Disorders (NIDCD)" with 1 trials as a collaborator and "University of Texas" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Austin Speech Labs" are "Aphasia" (3 trials) and "Language" (2 trials). Many other conditions were trialed in "Austin Speech Labs" in a lesser frequency.

Most popular intervention types in "Austin Speech Labs" are "Other" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Intensive Phonology Treatment" (1 trials), "Intensive SFA Treatment" (1 trials), "Intensive Speech Therapy" (1 trials), "Real tDCS" (1 trials) and "Semantic Feature Analysis (SFA)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Austin Speech Labs" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Austin Speech Labs". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Austin Speech Labs, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Austin Speech Labs, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".